Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Idea to Innovation

University of Alberta

$125,000.00

Functional Derivatives of Maleic Acid copolymers and Native Nanodisc Technology (FUNDEMANNT)_x000d_ [Phase 1]

FY 2020-21

Summary
TEC Edmonton filed a US provisional patent application on October 23, 2019 that describes Dr. Overduin's invention relating to a series of functionalized derivatives of maleic acid copolymers which are used for solubilization, purification, manipulation and visualization of hydrophobic materials such as lipids or membrane proteins, the water-soluble nanodiscs formed between said copolymers and hydrophobic materials,methods for preparing said complexes, and the applications of said complexes, particularly to analytical, screening or diagnostic purposes. The US provisional patent application will be converted to a formal PCT application by October 23, 2020, at which point new data will be incorporated regarding the use of this copolymers and methods with additional cells, tissues, and membrane proteins to form nanodiscs as well as accompanying biophysical and biochemical characterization. The subsequent national phase deadline will be pursued in order to maintain patent protection in the US, Canada, and Europe to allow for future research and to retain industry interest. Based on past expenditures, we estimate that our total filing costs in the aforementioned jurisdictions will be $10,000, for which we are asking half to be reimbursed by I2I funding. Over the course of this grant, we will continue to engage with potential licensees to ensure mutual ongoing benefit, and will work towards our goal of securing license agreements and contract services.
Program
Idea to Innovation
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
548807-2020
Name nom
Overduin, Michael
Department département
Biochemistry
Organization id
9
Institution établissement
University of Alberta
Province en
Alberta
Province fr
Alberta
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2020
Competition year année de concours
2020
Award amount
125000
Program id
I2IPJ
Program name en
Idea to Innovation
Program name fr
De l'idée à l'innovation
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
5403
Research subject group en
Biochemistry
Research subject group fr
Biochimie
Research subject en
Proteins and peptides, amino acids
Research subject fr
Protéines et peptides, acides aminés
Installment
inst:1 - 1
Partie
1
Nb partie
1
Application title
Functional Derivatives of Maleic Acid copolymers and Native Nanodisc Technology (FUNDEMANNT)_x000d_ [Phase 1]
Keyword
NSERC
Application summary
TEC Edmonton filed a US provisional patent application on October 23, 2019 that describes Dr. Overduin's invention relating to a series of functionalized derivatives of maleic acid copolymers which are used for solubilization, purification, manipulation and visualization of hydrophobic materials such as lipids or membrane proteins, the water-soluble nanodiscs formed between said copolymers and hydrophobic materials,methods for preparing said complexes, and the applications of said complexes, particularly to analytical, screening or diagnostic purposes. The US provisional patent application will be converted to a formal PCT application by October 23, 2020, at which point new data will be incorporated regarding the use of this copolymers and methods with additional cells, tissues, and membrane proteins to form nanodiscs as well as accompanying biophysical and biochemical characterization. The subsequent national phase deadline will be pursued in order to maintain patent protection in the US, Canada, and Europe to allow for future research and to retain industry interest. Based on past expenditures, we estimate that our total filing costs in the aforementioned jurisdictions will be $10,000, for which we are asking half to be reimbursed by I2I funding. Over the course of this grant, we will continue to engage with potential licensees to ensure mutual ongoing benefit, and will work towards our goal of securing license agreements and contract services.